Delivery Order SPE2DX22D0010-SPE2D824FAD52
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,565,724,223 dextroamphetamine 20 mg tablets in packages of 30. The fixed-price delivery order, valued at $1,080.66, has a completion date of September 9, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through...
- This federal contract award, solicited and awarded by the Defense Logistics Agency (DLA), was granted to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,274.86 firm-fixed-price delivery order contract covers the provision of 4,566,975,300 units of dextroamphetamine-amphetamine 10 mg tablets. The contract has an ultimate completion date of January 21, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,243.38 firm fixed-price delivery order is for the supply of 4,568,254,602 tablets of the prescription medication dextroamphetamine-amphetamine 10 mg. The contract has an ultimate completion date of May 15, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,525.60 firm fixed-price delivery order is for the supply of 4,566,601,642 units of dextroamphetamine 5 mg tablets in 100-count bottles. The contract has an ultimate completion date of December 4, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of 4,567,722,276 units of 10 mg dextroamphetamine tablets. The contract has a ceiling value of $1,238.20 and runs through March 27, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4,564,728,550 units of 10 mg dextroamphetamine tablets, with a ceiling value of $4,143.30 and a completion date of May 29, 2024. The contract is a Delivery Order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 31, 2025. This...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,558,601,061 units of Dextroamphetamine-Amphetamine 10 mg tablets in 100-count bottles. The award, valued at $1,184.59, is a firm fixed-price delivery order contract with a completion date of September 26, 2022. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen, as the prime...
- This is a federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,078.08, is a delivery order contract for the supply of dextroamphetamine-amphetamine 10 mg tablets. The contract has a firm fixed price and an ultimate completion date of February 20, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...
- This federal contract award is for the delivery of 4559477184 units of 10mg dextroamphetamine tablets, with a ceiling value of $3,178.93. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 30, 2022, with a planned completion date of January 3, 2023. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999...
- This federal contract award was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,127.24 firm fixed-price delivery order is for the supply of 4,566,432,279 units of dextroamphetamine 5 mg tablets. The contract has an ultimate completion date of November 15, 2024 and was awarded on November 14, 2024. This contract award is part of a larger $999,999,999 Indefinite Delivery...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D824FAD52Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, to Amerisourcebergen Drug Corp., a major pharmaceutical distributor. The contract, valued at $2,709.02, is for the delivery of 4,562,376,802 dextroamphetamine tablets, 10 mg, with an ultimate completion date of October 4, 2023. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 31, 2025. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award was made through full and open competition without any set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 10/3/23 |